The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Advocates for Dedicated Department of Defense Arthritis Research Funding

ACR Advocates for Dedicated Department of Defense Arthritis Research Funding

January 16, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Rheumatic disease disproportionately affects active members and veterans of the armed forces, and the U.S. Department of Defense (DOD) is explicitly charged with funding research on diseases that affect members of the military. For the past several years, the ACR and RheumPAC have teamed up with the Arthritis Foundation to advocate for dedicated arthritis research funding as part of the DOD’s Congressionally Directed Medical Research Program (CDMRP), which was created in 1992 to promote biomedical research that benefits both service members and the American public.

You Might Also Like
  • RheumPAC Advocates for Department of Defense Arthritis Research Funding
  • The ACR Joins Call for Dedicated Arthritis Research Funding to Help Veterans
  • RheumPAC Advocates for Dept. of Defense Arthritis Research Funding
Also By This Author
  • Free Certified Education Units (CEUs) for Coders

The ACR is working to secure $20 million dedicated to arthritis-focused medical research through the House defense appropriations process in the annual CDMRP budget. Among the points we make to lawmakers are:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Rheumatoid arthritis is more prevalent among service members and veterans than in the general population. Approximately one in three veterans has arthritis, compared with one in four U.S. adults, according to the U.S. Centers for Disease Control & Prevention. And the incidence of osteoarthritis is more than twice as high in the military population over the age of 40 compared with the general population, showing a clear need for better prevention and treatment in this population.1,2
  • Osteoarthritis affects both the number and readiness of available service members. It is the leading cause of disability among U.S. veterans and the most common condition resulting from battle injury that leads to medical discharge from the military.3,4 In addition, arthritis is the leading cause of disability among veterans, with 32% reporting doctor-diagnosed arthritis compared with 22% of non-veterans.5

One of the ACR’s volunteer leaders, Colin C. Edgerton, MD, FACP, RhMSUS, chair of the ACR Committee on Rheumatologic Care, has seen the toll that arthritis takes on men and women in the armed services. As rheumatology service chief at Eisenhower Army Medical Center, Fort Gordon, Ga., Dr. Edgerton was responsible for evaluating soldiers who were being medically discharged due to their arthritis symptoms, joint damage and disability. Now in private practice in North Charleston, S.C., Dr. Edgerton volunteers his time to educate lawmakers about how arthritis affects service members and veterans. He has made many trips to Washington, D.C., to talk with legislators and their staffs, offer presentations in Hill briefings and meet with Pentagon officials on this topic.

Currently, DOD funding for arthritis research may be obtained through broader programs, such as the Peer Review Medical Research Program, dependent on Senate delegation of the funds. Over the past 20 years, an average of $4.25 million per year has been awarded for arthritis-focused projects.6 These awards have yielded important advances, such as the development of new cartilage-penetrating nanocarriers for improved drug delivery to treat osteoarthritis.7 However, researchers across many disciplines must compete for the same funding, and the grants are difficult to secure. In addition, funding levels change each year based on budget appropriations, making such grants an unreliable source of arthritis research funding.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR and RheumPAC, together with the Arthritis Foundation, are advocating for a dedicated line item in the CDMRP budget to allocate $20 million per year for arthritis research to better understand how to keep our service members healthy, allow them to conclude their careers on their own terms and live more comfortably in retirement. Visit the ACR’s Legislative Action Center to ask lawmakers to support funding for a dedicated DOD arthritis research program.

References

  1. Cameron KL, Hsiao MS, Owens BD, et al. Incidence of physician-diagnosed osteoarthritis among active duty United States military service members. Arthritis Rheum. 2011 Oct;63(10):2974–2982.
  2. Kopec JA, Rahman MM, Berthelot JM, et al. Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol. 2007 Feb;34(2):386–393.
  3. Cross JD, Ficke JR, Hsu JR, et al. Battlefield orthopaedic injuries cause the majority of long-term disabilities. J Am Acad Orthop Surg. 2011;19 Suppl 1:S1–S7.
  4. Rivera JC, Wenke JC, Buckwalter JA, et al. Posttraumatic osteoarthritis caused by battlefield injuries: The primary source of disability in warriors. J Am Acad Orthop Surg. 2012;20 Suppl 1:S64–S69.
  5. Dominick KL, Golightly YM, Jackson GL. Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare. J Rheumatol. 2006 Feb;33(2):348–354.
  6. Department of Defense. Congressionally directed medical research programs.
  7. Geiger BC, Wang S, Padera RF Jr., et al. Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis. Sci Transl Med. 2018 Nov 28;10(469). pii: eaat8800.

Pages: 1 2 | Multi-Page

Filed Under: From the College, Legislation & Advocacy Tagged With: Arthritis, Arthritis Foundation, Department of Defense (DoD), Research Funding, RheumPAC

You Might Also Like:
  • RheumPAC Advocates for Department of Defense Arthritis Research Funding
  • The ACR Joins Call for Dedicated Arthritis Research Funding to Help Veterans
  • RheumPAC Advocates for Dept. of Defense Arthritis Research Funding
  • The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)